P-tau181 has been shown to progressively increase with age in LBD cases, while is found high early on in the AD course[75]; as well as was able to best identified amyloid and tau PET abnormalities in DLB patients, supporting peripheral biomarker detection of AD co-pathology in Lewy body disease [76]. Here, MAPT is linked to Lewy body dementia.